GC
NVS icon

Gratus Capital’s Novartis NVS Stock Holding History

Gratus Capital’s Portfolio NVS Stock Details NVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		$208K Buy
+1,951
New +$196K 0.01% 344
2021
Q1 		– Sell
-3,336
Closed -$315K – 193
2020
Q4 		$315K Buy
+3,336
New +$292K 0.04% 146
2020
Q3 		– Sell
-9,234
Closed -$806K – 174
2020
Q2 		$806K Sell
9,234
-197
-2% -$17K 0.14% 109
2020
Q1 		$778K Sell
9,431
-1,142
-11% -$102K 0.15% 112
2019
Q4 		$1M Sell
10,573
-325
-3% -$29.2K 0.15% 113
2019
Q3 		$947K Sell
10,898
-1,076
-9% -$96.6K 0.15% 108
2019
Q2 		$1.09M Sell
11,974
-2,663
-18% -$225K 0.18% 107
2019
Q1 		$1.26M Sell
14,637
-362
-2% -$29.1K 0.21% 101
2018
Q4 		$1.15M Sell
14,999
-956
-6% -$74.4K 0.24% 101
2018
Q3 		$1.23M Sell
15,955
-91,923
-85% -$6.8M 0.17% 95
2018
Q2 		$7.3M Sell
107,878
-713
-0.7% -$49.2K 1.08% 22
2018
Q1 		$7.87M Sell
108,591
-16,218
-13% -$1.23M 1.13% 16
2017
Q4 		$9.39M Buy
124,809
+13,690
+12% +$1.03M 1.22% 16
2017
Q3 		$8.55M Buy
111,119
+2,743
+3% +$207K 1.19% 17
2017
Q2 		$8.11M Buy
108,376
+1,855
+2% +$131K 1.16% 18
2017
Q1 		$7.09M Buy
106,521
+8,628
+9% +$575K 1.02% 27
2016
Q4 		$6.39M Buy
97,893
+77,639
+383% +$5.04M 0.96% 30
2016
Q3 		$1.43M Sell
20,254
-439
-2% -$32K 0.21% 92
2016
Q2 		$1.53M Buy
+20,693
New +$1.43M 0.22% 87

Other funds holding NVS

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
CCM
Cullen Capital Management New York $9.75B AUM 21.81% 1-Year Est. Return

Gratus Capital's NVS Position: Q2 2024 in Review

Gratus Capital opened a new position in Novartis (NVS) in Q2 2024: 1,951 shares worth $208K. The stake represents 0.01% of the portfolio and ranks #344 among its holdings. This is a return to the name: Gratus Capital previously reported a position in NVS as recently as Q4 2020.

Gratus Capital first reported a position in NVS in Q2 2016 and has held it in 19 quarters since. The position peaked at $9.39M in Q4 2017. 1,306 funds tracked by Wall St. Rank hold NVS as of Q2 2024.

  • Gratus Capital held 1,951 shares of Novartis worth $208K as of Q2 2024.
  • Novartis was a new Gratus Capital position in Q2 2024.
  • Novartis made up 0.01% of Gratus Capital's portfolio in Q2 2024, its #344 holding.
  • Gratus Capital first reported a position in Novartis in Q2 2016 and has held it in 19 quarters since.
  • Gratus Capital's Novartis position peaked at $9.39M in Q4 2017.
  • 1,306 funds tracked by Wall St. Rank held Novartis as of Q2 2024.

Based on Gratus Capital's 13F filing for Q2 2024, filed 25 Jul 2024.